Biocom California invites you to mix and mingle with your fellow CFOs within the life sciences industry at this informal networking reception. These receptions are designed for CFOs of life science companies to network with one another on a peer‐to‐peer level and provides a venue for CFOs to discuss pertinent, informative issues, as well as learn...
Designing and Optimizing PROTACs, Molecular Glues and Other Degrader Modalities The ubiquitin-proteasome, lysosome and autophagy systems are all well-controlled, selective degradation pathways that are key cellular regulators in cancer, CNS and other diseases. A new generation of hetero bi-functional chimeras and small molecule monovalent degraders are being developed to hijack these systems for targeted protein...
Emerging Strategies for Multiomics in Precision Medicine An in-person and live streamed event This event, part of the Precision Medicine Leaders’ Summit conference series and developed in partnership with the University of Pennsylvania Center for Precision Medicine, will explore how multiomics methods are advancing precision medicine in a range of human disease areas. Recent advances...
BVS in collaboration with BioMed Realty are hosting an outdoor Biotech Community Innovation Night at Termeer Square. This event will be held in Termeer Square in the heart of Kendall Square which has Amgen, Alnylam, Merrimack, Takeda Pharmaceuticals, and many others located in this vicinity. Kendall Square, which has been labeled “the most innovative square...
What You'll Learn: How mature is Philadelphia’s life sciences cluster and what is the path to reaching national and global competitiveness? How do local education and talent generation compare to other national institutions and what is being done to retain key talent? With so much competition for capital globally, how is Philadelphia securing its slice...
What You'll Learn: Move over, San Francisco — the Washington/Baltimore region beats the Bay Area in life sciences research talent, according to CBRE. What helped bring the Mid-Atlantic into the life science limelight, and how can it keep its place in the top two? What new economic drivers and incentives, from D.C. government to Frederick County,...
Gene Editing: Where are we, where are we going We will explore the state of gene editing and how Philadelphia-area researchers and companies are helping advance the field of medicine that gives scientists the ability to change an organism's DNA. Gene editing, also known as genome editing, is the process of altering the genetic material...
Save the date for the American Diabetes Association’s 83rd Scientific Sessions in San Diego, CA, June 23-26, 2023 at the San Diego Convention Center. We know you are eager to participate in-person, to network with colleagues, hear the latest scientific advances and groundbreaking research presentations, and experience the Exhibit and Poster Halls. Should you have any questions,...
@Philly Cell and Gene Therapy Annual Conference 2023 (In-Person) In-Person, Jun 23 - 24, 2023 Sheraton Valley Forge Hotel 480 N Gulph Rd King of Prussia, PA 19406 Please check our website for detailed agenda and speakers information. Recognized for its pharmaceutical legacy, the Greater Philadelphia area is now poised to become a leading worldwide Cell &...
At this day-long symposium, 2020 - 2022 Ono Pharma Foundation awardees will present their latest research and findings. It will also include, a special presentation by Nobel Laureate, Carolyn Bertozzi, a round-table luncheon and a post-event reception.
What You’ll Learn From San Francisco CRE Leaders: Why has Northern California become such a hot life sciences market and how are owners adjusting to meet this demand? Have new tenant demands regarding safe workplaces been beneficial or restrictive for owners and landlords? Considering the changes in office leasing activity, are industry leaders repurposing office...
NewYorkBIO has partnered with NYSE to bring together New York's financial community and emerging companies developing novel therapeutics in areas which could revolutionize patient care.
